Chitosan-coated poly(є-caprolactone) nanocapsules for mucoadhesive applications of perillyl alcohol
Source abstract
Abstract
Perillyl alcohol (POH) is an essential oil found in several plants and presents significant therapeutic and chemo-preventive activity against some tumors. However, it exhibits low aqueous solubility and thereby reduced oral absorption and bioavailability. Nanoencapsulation of POH can be an important tool to overcome such limitations. In this work, chitosan was used for coating poly (ε-caprolactone) nanocapsules for mucoadhesive applications of POH. The nanocapsules were obtained by the nanoprecipitation method and presented a mean diameter of about 330 nm, spherical morphology, polydispersity index of 0.14, zeta potential of +32 mV, and POH encapsulation efficiency of 56%. POH was prolonged released from nanocapsules. In mucoadhesion studies, nanocapsules showed higher adsorption to mucin compared to free POH, possibly due to electrostatic interactions between chitosan and mucin. In the cytotoxicity assay, POH-loaded nanocapsules presented higher IC50 than free POH; however, they were more selective for HT-29 tumor cells than for normal Vero cells. The results demonstrate the potential application of chitosan-coated nanocapsules for the oral administration of POH intended for cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Carbohydrate Chemistry and Synthesis · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, Laboratory of Pharmaceutical Nanotechnology, Universidade Estadual do Centro-Oeste/UNICENTRO, Guarapuava, PR, Brazil
Department of Pharmacy, Laboratory of Technological Innovation in the Development of Drugs and Cosmetics, Universidade Estadual de Maringá-UEM, Maringá, PR, Brazil
Funding
CNPq · Coordenação de Aperfeiçoamento de Pessoal de Nível Superior · Financiadora de Estudos e Projetos · Fundação Araucária
References (49)
Show source-provided references
1. 10.1371/journal.pone.014171910.1371/journal.pone.0141719 ↗
2. 10.1007/s00280-007-0585-610.1007/s00280-007-0585-6 ↗
3. 10.1007/978-3-030-31269-5_1510.1007/978-3-030-31269-5_15 ↗
4. 10.1016/j.ijpharm.2003.09.02610.1016/j.ijpharm.2003.09.026 ↗
5. 10.1016/B978-0-12-802215-3.00002-110.1016/B978-0-12-802215-3.00002-1 ↗
6. 10.1016/j.canlet.2007.07.02010.1016/j.canlet.2007.07.020 ↗
7. Mukhtar Y. M. · Biosci. Rep. · 2018 · 38 · BSR2018125310.1042/BSR20181253 ↗
8. 10.1158/1940-6207.CAPR-09-018310.1158/1940-6207.CAPR-09-0183 ↗
9. Chen T. C. · Am. J. Cancer Res. · 2015 · 5 · 1580
10. Chen T. C. · Int. J. Mol. Sci. · 2018 · 19 · 1
11. Faria G. M. · BMC Cancer · 2020 · 20 · 29410.1186/s12885-020-06802-8 ↗
12. Santos J. G. · Oncol. Lett. · 2018 · 15 · 1263
13. 10.1007/s00432-010-0873-010.1007/s00432-010-0873-0 ↗
14. 10.1016/j.colsurfb.2012.06.02410.1016/j.colsurfb.2012.06.024 ↗
15. 10.1016/j.ijpharm.2010.05.02010.1016/j.ijpharm.2010.05.020 ↗
16. Li H. · Curr. Opin. Solid State Mater. Sci. · 2002 · 6 · 310.1016/S1359-0286(02)00008-6 ↗
17. 10.1016/j.ijpharm.2012.01.05110.1016/j.ijpharm.2012.01.051 ↗
18. 10.1016/j.reactfunctpolym.2020.10449310.1016/j.reactfunctpolym.2020.104493 ↗
19. 10.3390/ijms1906179510.3390/ijms19061795 ↗
20. 10.1080/21691401.2018.147778810.1080/21691401.2018.1477788 ↗
21. 10.1016/j.ejpb.2015.04.02510.1016/j.ejpb.2015.04.025 ↗
22. 10.3390/polym1003026710.3390/polym10030267 ↗
23. 10.1016/j.foodhyd.2019.03.04210.1016/j.foodhyd.2019.03.042 ↗
24. 10.1016/j.ijpharm.2010.08.02010.1016/j.ijpharm.2010.08.020 ↗
25. 10.3390/pharmaceutics1001003410.3390/pharmaceutics10010034 ↗
26. Wang M. · Int. J. Nanomed. · 2013 · 8 · 1141
27. da Silva Santos J. · Biomed. Chromatogr. · 2020 · e5037
28. 10.1016/0378-5173(89)90281-010.1016/0378-5173(89)90281-0 ↗
29. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
30. 10.1517/17425247.2011.58633410.1517/17425247.2011.586334 ↗
31. 10.1517/17425247.2013.76995610.1517/17425247.2013.769956 ↗
32. 10.1016/S1773-2247(10)50043-110.1016/S1773-2247(10)50043-1 ↗
33. 10.1016/j.colsurfb.2014.01.01110.1016/j.colsurfb.2014.01.011 ↗
34. 10.1155/2014/72015710.1155/2014/720157 ↗
35. Borjigin M. · Int. J. Nanomed. · 2013 · 8 · 855
36. 10.1016/j.carbpol.2010.02.02610.1016/j.carbpol.2010.02.026 ↗
37. 10.1016/j.ijbiomac.2015.08.01010.1016/j.ijbiomac.2015.08.010 ↗
38. Cavendish M. · J. Therm. Anal. Calorim. · 2020 · 141 · 76710.1007/s10973-019-09080-0 ↗
39. 10.1016/S0169-409X(01)00112-010.1016/S0169-409X(01)00112-0 ↗
40. Del R. G. · Carbohydr. Polym. · 2018 · 202 · 34510.1016/j.carbpol.2018.08.142 ↗
41. 10.1097/ACI.0b013e32831d815c10.1097/ACI.0b013e32831d815c ↗
42. dos P. · Eur. J. Pharm. Biopharm. · 2017 · 114 · 8810.1016/j.ejpb.2017.01.007 ↗
43. 10.1016/j.jcis.2011.12.06310.1016/j.jcis.2011.12.063 ↗
44. 10.1016/j.ijpharm.2016.03.01310.1016/j.ijpharm.2016.03.013 ↗
45. 10.1016/j.ejpb.2015.05.00410.1016/j.ejpb.2015.05.004 ↗
46. 10.1016/j.ejpb.2015.03.02710.1016/j.ejpb.2015.03.027 ↗
47. Fernández Freire P. · Toxicology · 2005 · 210 · 3710.1016/j.tox.2005.01.009 ↗
48. Koyama M. · Oncol Rep. · 2013 · 29 · 77910.3892/or.2012.2167 ↗
49. 10.3109/13880209.2015.110375310.3109/13880209.2015.1103753 ↗